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Dendritic cells (DCs) are professional antigen presenting cells (APC) capable of induction of primary immune responses as well as
immunologic tolerance. Myeloid and lymphoid subsets of murine DCs are able to shift cytokine responses of T cells toward Th2
and Th1 profiles respectively. Thus, DCs would be suitable candidates to mediate the balance of maternal immune responses to
conception. We analyzed pregnancy-related variations in uterus and splenic DCs in a murine model. C57BL/6-mated Balb/c
female mice with vaginal plugs were scarified at early, middle, and late pregnancy. Frozen sections of uterus and spleen at each
stage of pregnancy were immunostained with CD11c- and MHC-II-specific antibodies. Two-color immunohistochemistry was
also carried out using anti-CD11c and one of the antibodies against CD11b, CD8a, CD86, and DEC-205. Using morphometric
analysis, the average density of DCs and relative percentage of myeloid (CD11cC, CD11bC) and lymphoid DCs (CD11cC,
CD8aC) were determined at each stage. Our results showed that DCs are present throughout the pregnancy in decidua. The
average density of decidual DCs at early pregnancy was significantly higher relative to middle and late gestation or to those of
endometrial DCs of non-pregnant mice. Interestingly, the average density of decidual and splenic DCs, followed the same
variations at different stages of pregnancy. The relative percentage of decidual lymphoid DCs (LDC) was significantly higher at
mid-gestation when compared with other stages of pregnancy or non-pregnant mice. Inversely, the frequency of myeloid DCs
(MDC) and the MDC/LDC ratio were statistically lower at the middle stage of pregnancy. A majority of decidual DCs expressed
MHC-II and CD86. At early pregnancy, DCs were more concentrated subadjacent to the luminal epithelial layers, whereas at mid-
or late gestation, DCs were randomly distributed in the stroma and around the epithelium. Mid-pregnancy period was a critical
point with regard to splenic DCs kinetics, as both the average density of DCs and the frequency of MDCs decreased significantly
when compared with early or late pregnancy, although the relative percentage of splenic LDCs did not change. Our data suggest
that the balance of MDC and LDC is finely tuned throughout pregnancy, pointing an eminent immunoregulatory role of DCs in the
maintenance of pregnancy.
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Dendritic cells (DCs) are the most potent antigen
presenting cells (APC), which are essential for initiation
of primary immune responses (Steinman 1991, Bancher-
eau et al. 2000). These cells serve as the key regulators of
immunologic mechanisms and depending on their
subsets may induce immunity or immunologic toler-
ance. DC subsets may provide T cells with the different
cytokine/molecule microenvironments that determineq 2007 Society for Reproduction and Fertility
ISSN 1470–1626 (paper) 1741–7899 (online)the classes of immune response, for example, type 1
versus type 2 CD4 helper cell profiles (Moser & Murphy
2000). At least two distinct pathways of DC development
have been identified in mice, myeloid, and lymphoid
(Steinman et al. 1997, Vremec & Shortman 1997).
Myeloid DCs (MDC) express CD11c and CD11b and
induce a vigorous proliferative response in CD4CT cells,
whereas lymphoid DCs (LDC) express CD11c, CD8a,
and DEC-205 and induce a limited CD4CT cell responseDOI: 10.1530/rep.1.01232
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276 A-H Zarnani and othersthat is associated with marked T-cell apoptosis (Suss &
Shortman 1996, Vremec et al. 2000). Both subsets
express high levels of class II major histocompatibility
complex (MHC-II) and the co-stimulatory molecules,
CD86 and CD80 (Banchereau et al. 2000).
The mechanisms leading to the fact that semiallogenic
fetus is not rejected by the maternal immune system have
not been completely understood and in this regard
several hypotheses have been proposed. It has been
postulated that during pregnancy a local phenomenon of
non-specific immunosuppression might take place.
Tolerance induction during pregnancy is likely to be
related to the unique cocktail of hormones, cytokines,
and immunoregulatory cells present at the site of
blastocyst implantation (Thellin et al. 2000). There are
plenty of reports indicating the presence of an immuno-
suppressive microenvironment at the feto-maternal
interface. Fas/FasL induced apoptosis of the immune
cells circulating to decidua (Hunt et al. 1997, Jerzak
et al. 1998), presence of complement regulatory proteins
at the feto-maternal interface (Holmes et al. 1990, 1992,
Xu et al. 2000), immunoregulatory function of placental
indoleamine 2,3 dioxygenase, an enzyme involved in
tryptophan catabolism (Kamimura et al. 1991, Munn
et al. 1998), inhibition of natural killer (NK) cell-
mediated cytotoxicity by human leukocyte antigen
(HLA)-G and HLA-E (McMaster et al. 1995, King et al.
2000), and pivotal role of regulatory T cells in induction
of maternal tolerance to paternal alloantigens (Saito et al.
2005, Zenclussen 2005) all are the immunosuppressive
mechanisms which are involved in the protection of
semiallogenic fetuses. Besides the immunosuppressive
mechanisms mentioned above, the cytokine environ-
ment during pregnancy is also critical for successful
pregnancy. According to several reports, a T-helper
(Th)-2 response is necessary for a successful fetal
outcome, while a Th1 response results in increased
fetal loss (Lin et al. 1993, Jenkins et al. 2000, Lim et al.
2000, Piccinni et al. 2000, Croy 2001, Makhseed et al.
2001). For example, fetal loss in abortion-prone CBA/j!
DBA/2 mating is due to a deficiency in the production of
Th2 cytokines (Rajagopalan & Long 1999). In humans,
deviation from a Th2 cytokine response leads to
spontaneous abortion as well (Hill et al. 1995,
Raghupathy 2001). Although many attempts have been
made to highlight the supporting role of Th2 cytokines,
there are also some reports indicating that Th1 cytokines
may serve a pivotal role during pregnancy (Svensson
et al. 2001, Chaouat et al. 2002, 2004a, 2004b). It must
be taken into consideration, however, that there are
sequential windows of Th1/Th2 dominance and preg-
nancy is associated with very precise timing and tuning
of such cytokines as, for example, Th1 cytokines exert
their supporting role during early gestation period
(Chaouat et al. 2002).
Regarding the importance of Th2 immunity as well as
induction of tolerance to fetal allograft during pregnancy,Reproduction (2007) 133 275–283and having considered the mutual role of DCs in
induction of immunity versus tolerance and Th1 versus
Th2 immune responses, it seems that these cells would
be potentially suitable candidates to mediate the balance
of maternal immune responses against pathogens, while
retaining its capacity to support pregnancy. In fact, there
is evidence that DCs could play a protective role at the
human feto-maternal interface (Kammerer et al. 2000).
In our recent report, we showed variations of murine
endometrial DC subsets during estrous cycle (Zarnani
et al. 2006). In this study, we evaluated the frequency,
localization, and immunophenotype, with emphasis on
myeloid and lymphoid markers, of murine decidual DCs
during early, middle, and late stages of pregnancy. In
addition, to address the systemic effect of pregnancy on
DC kinetics, the same variables were studied in splenic
DC populations.Materials and Methods
Animals
Female Balb/c mice (8–12 weeks) were prepared from
Pasteur Institute of Iran. Mice were kept under optimal
conditions of hygiene, temperature, and humidity with
12 h light:12 h darkness cycle and were allowed food
and water ad libitum. All experimental procedures on
animals were approved by the ethical committee of
Avesina Research Institute (ARI).Determination of gestational age
Female Balb/c mice were allowed to mate with a male
C57BL/6 and checked daily for the presence of vaginal
plug. Females with vaginal plug were separated and
examined for the presence of sperm in vaginal smear.
The day of vaginal plug and sperm detection was
considered to be the day 0.5 of pregnancy.Tissue specimens
Non-pregnant mice and pregnant mice on gestation days
(GD) 2, 11, or 18, corresponding to early, middle, and
late pregnancy periods respectively, were killed and the
middle one-third of left horn of the uterus as well as
spleen were removed simultaneously. Frozen sections of
the tissues were cut at 5 mm thickness, transferred to glass
slides, air-dried at room temperature for 8 h and fixed in
ice-cold acetone for 2 min. The slides were then stored at
K70 8C until used.Antibodies
The primary and secondary antibodies used in this study
together with their clone, origin, isotype, and optimal
working dilutions are listed in Table 1.www.reproduction-online.org
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Table 1 Primary and secondary antibodies used for immunohisto-
chemical staining.
Antigen Clone
Species/
isotype
Working
dilutionsa Supplier
CD8a 83-6.7 Rat/IgG2a 1:250 Pharmingen
DEC-205 NLDC-145 Rat/IgG2a 1:10 Serotech
CD86 GL1 Rat/IgG2a 1:70 Pharmingen
CD11b M1/70 Rat/IgG2b 1:250 Pharmingen
CD11c HL3 Hamster/IgG
group 1
1:70 Pharmingen
I-A/I-E 2G9 Rat/IgG2a 1:250 Pharmingen
Rat Igb – Goat
(multiple-
adsorbed)
1:70 Pharmingen
Hamster
IgGc
G70-
204/G94-56
Mouse/IgG1
and IgG2b
1:250 Pharmingen
aAll dilutions were made with antibody diluent (Pharmingen, Sydney,
Australia). bHRP-conjugated. cBiotin-conjugated.
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Acetone-fixed cryostat sections of uterus and spleen
were thawed and washed thrice with 0.15 M TBS (Tris-
buffered saline, pH 7.4). The slides were then incubated
for 10 min with 5% normal mouse, goat or rat sera
appropriately diluted in TBS to block non-specific
bindings. For MHC-II staining, the slides were incubated
with appropriate dilution of biotin-conjugated rat anti-
mouse I-A/I-E for 1 h. Following three washes, endogen-
ous peroxidase activity was quenched by the addition of
0.3% H2O2 in TBS. After washing with TBS, slides were
incubated with horse radish peroxidase (HRP)-conju-
gated streptavidin (Biosource International, NY, USA)
diluted in a ratio of 1:50 in TBS for 30 min. Excess
reagents were washed off by washing thrice with TBS
followed by the addition of NiSO4-supplemented
diaminobenzidine (DAB; Sigma) as substrate. Sections
were counterstained with Harris hematoxylin (Sigma),
dehydrated with ascending grades of ethanol each for
30 s and mounted in Entellan (Merck).
Staining with anti-CD11c differed from the above
procedure in that the slides were stained with hamster
anti-mouse CD11c, followed by incubation with biotin-
conjugated mouse anti-hamster IgG for 45 min. The
staining was completed as above.
For DEC-205, CD8a, CD11b, and CD86 staining,
briefly, sections were sequentially incubated with
optimally diluted primary antibodies followed by
washing and addition of HRP-conjugated goat anti-rat
secondary antibody. The sections were then developed
and processed as above.Two-color immunohistochemistry
Adaptation for immunohistochemical double staining
was as follows: briefly, tissue sections were sequentially
incubated with appropriate dilutions (Table 1) of
hamster anti-mouse CD11c and of rat anti-mouse
DEC-205, CD8a, CD11b, or CD86 monoclonalwww.reproduction-online.organtibodies for 75 min at room temperature followed
by a mixture of HRP-conjugated goat anti-rat immu-
noglobulin and biotin-conjugated mouse anti-hamster
IgG, and alkaline phosphatase-conjugated avidin–biotin
complex (ABC; DAKO, Glostrup, Denmark). The
peroxidase activity was visualized first in a controlled
manner under light microscope using DAB as substrate.
Following three washes with TBS, the alkaline phos-
phatase activity was developed by 20–30 min incu-
bation in the alkaline phosphatase blue substrate
(Vector Laboratories, Burlingame, CA, USA). Next, the
sections were rinsed in tap water, counterstained with
nuclear fast red (DAKO, Glostrup, Denmark), dehy-
drated not more than 30 s in absolute ethanol, cleared
with Histoclear (Vector Laboratories), and mounted
with Vecta mount (Vector Laboratories). In these
preparations, the alkaline phosphatase activity yielded
a blue reaction product, whereas peroxidase activity
appeared brown. Levamisole (0.024%; Sigma) and
H2O2 (0.3%) were used to block endogenous alkaline
phosphatase and peroxidase activities respectively. For
co-localization of CD11c and MHC-II, serial sections of
tissues were stained separately with these antibodies. In
negative control slides, primary or secondary antibodies
were omitted. Species-matched control sera, diluted in
a ratio of 1:10, were also used, instead of primary
antibodies as isotype-matched Ab and the results were
shown to be always negative (Fig. 1d and h).Morphometry
To evaluate the relative percentage of DCs expressing
one of the markers of interest (CD8a, DEC-205, CD11b,
and CD86), double positive cells were counted at 400!
magnification in 40 individual fields of 0.0625 mm2
(totally 2.5 mm2) for each section and expressed as a
percentage of the total number of CD11cC cells. In
single-color immunostainings for CD11c, positive cells
were also counted in the same manner and expressed as
a percentage of the total number of nucleated cells.Statistical analysis
Five animals were used in each experimental group.
Comparisons were made by non-parametric Kruskal–
Wallis test. Correlation analysis was performed using
Pearson’s test. P!0.05 was considered statistically
significant.Results
Distribution of MDC and LDC in spleen and decidua
To identify distribution and localization of MDCs and
LDCs in spleen and decidua of pregnant mice, a total
number of five animals were used in each experimental
group. Tissue sections were stained for expression ofReproduction (2007) 133 275–283
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Figure 1 Immunostaining of dendritic cells in spleen and decidua of
pregnant Balb/c mice. Cryosections were prepared from spleen (a–d)
and uterus (e–h) of female mice and stained with CD11c. d and h are
negative control slides in which primary antibody was substituted by
species-matched control sera. (a–d, 100!; e–h, 200!). Black arrows
show decidual dendritic cells. NC, negative control; EP, early
pregnancy; MP, mid-pregnancy; LP, late pregnancy.
Figure 2 Comparative analysis of DCs (CD11cC), LDCs (CD11cC
CD8aC), and MDCs (CD11cC CD11bC) in spleen and decidua of
pregnant Balb/c mice. Non-pregnant mice served as controls.
Cryosections were prepared from spleen and uterus of female mice and
stained with CD11c (a and b). Positive cells were counted and
expressed as a percentage of the total number of nucleated cells. (a)
Frequency of splenic DCs declined to its lowest level during mid-
pregnancy when compared with early and late pregnancy periods or
non-pregnant mice (*P!0.01). (b) At early pregnancy, frequency of
decidual DCs was highest relative to other stages or non-pregnant mice
(*P!0.01). For immunophenotyping, double color immunohisto-
chemistry staining was carried out using CD11c and one of the CD8a
or CD11b antibodies. Double positive cells were counted and
expressed as a percentage of the total number of CD11cC cells. (c) At
all periods of pregnancy, relative percentage of splenic LDCs was
significantly increased, while those of MDCs decreased when
compared with non-pregnant mice (*P!0.05). Also, the relative
percentage of myeloid DCs was significantly lower at mid-gestation
when compared with early or late pregnancy (†P!0.05). (d) The middle
stage of pregnancy was a critical point in that relative percentages of
decidual LDCs and MDCs were reversed when compared with other
stages of pregnancy (*,†P!0.01). NP, non-pregnant; EP, early
pregnancy; MP, mid-pregnancy; LP, late pregnancy.
278 A-H Zarnani and othersCD11c, MHC-II, CD8a, DEC- 205, CD11b, and CD86 at
each stage of pregnancy.
Dendritic cells in spleen of pregnant mice
DCs were present throughout the gestation in spleen of
pregnant mice (Fig. 1a–c), but their percentage was
highest at early pregnancy and lowest at mid-gestation
(P!0.01; Fig. 2a). DCs were heavily distributed around
the lymphoid follicles of the white pulps with some
scattered in the red pulp (Fig. 1a). The average density of
splenic DCs at early, middle, and late pregnancy was
1.63G0.14, 0.93G0.17, and 1.35G0.1% respectively
(Fig. 2a). In all stages studied, no statistical difference
was found in relative percentage of lymphoid (CD11cC
CD8aC) DCs, although the relative percentage of MDCs
was significantly lower at mid-gestation when compared
with early or late pregnancy (P!0.05; Fig. 2c). On an
average, 65.2G3.4, 70.2G3.5, and 64.2G3.3% of
splenic DCs expressed CD8a at early, middle, and late
pregnancy respectively, while the relative percentage of
CD11bC DCs at the above stages was 36.5G4.7,Reproduction (2007) 133 275–28327.6G3.6, and 31.9G2.4%. At all periods of pregnancy,
the relative percentage of splenic LDCs was significantly
increased, while those of MDCs decreased when
compared with non-pregnant mice (P!0.05; Fig. 2c).
Our results also showed that the ratio of LDC/MDC at
mid-gestation in spleens of pregnant mice was signi-
ficantly higher than those of other stages (P!0.05; data
not shown). In addition, we found that the majority of the
splenic DCs express MHC-II (97.9G1.8) and CD86
(91.5G5.5) (Table 2). The expression of DEC-205 on
DCs correlated strictly with that of CD8a (rZ0.87;
Fig. 3). No differences were found between different
stages of pregnancy with regard to expression of CD86
and MHC-II on splenic DCs.
Dendritic cells in decidua of pregnant mice:
DCs were present in decidua at all stages of pregnancy
(Fig. 1e–g). The comparative analysis of decidual DCswww.reproduction-online.org
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Table 2 Expression of MHC-II and CD86 on splenic and decidual CD11cC dendritic cells during different periods of pregnancy.
Spleen Decidua
NP EP MP LP NP EP MP LP
MHC-II 97.3G2.2 98.2G1.7 98G1.9 97G1.6 98G1.5 98.6G1.4 99G0.6 97.8G1.9
CD86 85.3G6.2 92.3G4.8 88G5.1 94.2G6.7 87.9G5.4 91G2.8 93G4.7 95.1G5.6
NP, non-pregnant; EP, early pregnancy; MP, mid-pregnancy; LP, late pregnancy. Non-pregnant mice served as control.
Kinetics of murine decidual dendritic cells 279among three stages of pregnancy and non-pregnant mice
showed that the average density of decidual DCs was
significantly higher at early pregnancy (P!0.01; Fig. 2b).
The average density of DCs was 1.34G0.11, 0.46G0.05,
and 0.5G0.09% at early, middle, and late pregnancy
respectively. Interestingly, the average densities of
splenic and decidual DCs followed similar variations at
different stages of pregnancy. We examined the distri-
bution of decidual DCs at various stages of pregnancy.
DCs were present at all areas of uterus, including
myometrium, mesometrium, stroma, and subepithelial
layers. At early pregnancy, there were numerous DCs in
decidua concentrated subadjacent to the luminal
epithelial layers (Fig. 1e), whereas at middle or late
pregnancy DCs were randomly distributed in stroma and
around the glandular and luminal epithelial layers.
The relative percentage of LDCs was significantly
higher at mid-gestation when compared with early or
late pregnancy and non-pregnant mice (P!0.01;
Fig. 2d). We found that 35.1G4.3, 64.6G4, and
32.3G3.6% of decidual DCs expressed CD8a at early,
middle, and late pregnancy respectively. Inversely, the
relative percentage of decidual MDCs at middle
pregnancy was significantly lower in comparison with
other stages of pregnancy or non-pregnant mice
(P!0.01; Fig. 2d). The relative percentage of MDC at
early, middle, and late pregnancy was 64.6G3.9, 34.4G
5.5, and 64.3G4% respectively.
As expected, the LDC/MDC ratio was higher at mid-
gestation when compared with other stages (P!0.01;
data not shown). There was no statistical difference, with
regard to MHC-II or CD86 expression on decidual DCs
(Table 2), between various stages of pregnancy and the
majority of decidual DCs expressed these two markers.
Immunostaining with DEC-205 showed that as for
CD8a, DEC-205C CD11cC DCs were present in greater
numbers at mid-gestation (P!0.01).Figure 3 Expression of DEC-205 and CD8a on splenic CD11cC
dendritic cells during different periods of pregnancy. Non-pregnant
mice served as controls. As shown, there is considerable correlation
between the expressions of these markers on dendritic cells. NP, non-
pregnant; EP, early pregnancy; MP, mid-pregnancy; LP, late pregnancy.Discussion
In this study, we examined the relative percentage,
localization, and immunophenotype (with emphasis on
myeloid and lymphoid markers) of decidual and splenic
DCs of different stages of mouse pregnancy. Analysis of
DC frequency in spleen of pregnant mice revealed that
on an average, DCs comprised 1.3G0.11% of all splenic
nucleated cells, which was statistically similar to what
we found in non-pregnant mice (1.45G0.15%) (Zarnaniwww.reproduction-online.orget al. 2006). The average density of DCs was statistically
lower at mid-gestation when compared with other stages
of pregnancy or non-pregnant mice. We did not find any
report on splenic DCs during gestation. Published data
on peripheral DCs of pregnant women on different stages
of pregnancy, however, showed that the number of
peripheral blood DCs was significantly lower in the
second trimester, when compared with the first and third
trimesters of normal pregnancy (Rmochwal-Kolarz et al.
2003a, 2003b, Yoshimura et al. 2003). The reason for
this phenomenon is not clarified, but Kolarz et al.
(Rmochwal-Kolarz et al. 2003b) proposed that lower
frequency of blood DCs at mid-gestation is due to their
migration into the uterus. Our findings revealed that, in
parallel to splenic DCs, the frequency of decidual DCs
was also decreased at mid-gestation and therefore it does
not seem that such migration is responsible for this
phenomenon. It is possible that DCs are hormonally
controlled during normal pregnancy. In rats, pro-
gesterone concentration reaches the highest level at
mid-gestation (Varga et al. 1981) and a decrease in DC
frequency during this period may be associated with the
change in progesterone concentration.
Having considered that the relative frequency of
splenic LDCs increased (although this was not statisti-
cally significant), while those of MDCs decreased
significantly at mid-gestation, it seems that reduction in
splenic DC frequency during this period is mainly due to
a decrease in MDC populations.Reproduction (2007) 133 275–283
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280 A-H Zarnani and othersIt has recently been reported that the percentage of
LDCs and the LDC/MDC ratio were significantly lower in
the second trimester, when compared with the first or
third trimesters of normal human pregnancy (Rmoch-
wal-Kolarz et al. 2003b, Yoshimura et al. 2003). This
discrepancy can be explained by considering the
opposite functions of DC subsets, in human and in
mice. In human, myeloid and lymphoid DCs promote Th1
and Th2 immunities respectively, while in mice, MDCs
are proved to induce a Th2-biased response and LDCs
have the ability to induce a Th1-biased cytokine response
(Banchereau et al. 2000, Moser & Murphy 2000).
Furthermore, in contrast to non-pregnant mice in which
splenic myeloid and lymphoid DCs were present equally
(48.6G2.7 vs 50.3G3.4%), lymphoid DCs were more
prominent is spleens of pregnant mice (66.5G3.4 vs 32G
3.6%). We did not find statistical differences in MHC-II
and CD86 expression on splenic or decidual DCs
between various stages of pregnancy. However, regarding
the fact that we did not analyze quantitative expression of
these markers on DCs, the existence of such differences
could not be ruled out. Kammerer et al. (2000) reported
for the first time that CD83Cmature DCs were present in
the human decidua (mean densityZ4.97G1.88/mm2).
They later traced first-trimester decidual DCs using anti-
DC-SIGN antibody and showed that the frequency of
DC-SIGNC DC was 37G23/mm2, which was obviously
higher than the frequently of CD83C mature DCs
(Kammerer et al. 2003). Taking all these data into
account, it seems that in their first report, Kammerer
et al. underestimated the frequency of decidual DCs as
the majority of these cells were immature and CD83 is
expressed exclusively on mature DCs. Indeed, decidua is
a non-lymphoid tissue and DCs resident in such tissues
are generally immature, undergoing maturation only after
antigen uptake and migration to regional lymph nodes
(Banchereau et al. 2000).
It was recently reported that the frequency of murine
endometrial DCs was highest at estrus, a phase in estrous
cycle in which mating occurs (Zarnani et al. in press). In
the present study, we observed that mating was associated
with further recruitment of large numbers of DCs into the
early decidua. One important explanation for this
phenomenon may be the uptake and processing of
seminal proteins by DCs, leading to the induction of
appropriate immune response to paternal antigens. It
seems that DC recruitment to decidua is a feature of
inflammatory responses induced by insemination. Intro-
duction of the male ejaculate has been shown to cause
immediate changes in leukocyte populations in the
female reproductive tract of several species, including
rodents, pigs, rabbits, and humans (Lovell & Getty 1968,
Phillips & Mahler 1977, Pandya & Cohen 1985, De et al.
1991, Robertson & Sharkey 2001). Within hours of
mating in mice, specific factors in seminal plasma
including transforming growth factor b (TGF-b) originat-
ing in the seminal vesicles, target epithelial cells lining theReproduction (2007) 133 275–283uterine lumen to elicit a surge in release of proinflamma-
tory cytokines and chemokines, such as granulocyte-
monocyte colony stimulating factor (GM-CSF), interleu-
kin 6 (IL-6), and tumor necrosis factor a (TNF-a), which in
turn provoke an influx and activation of macrophages,
DCs, and neutrophils in a response resembling a clinical
inflammatory reaction (Robertson et al. 1996a, Tremellen
et al. 1998). According to Robertson et al. GM-CSF
receptor is expressed on the majority of endometrial
immune cells, including macrophages, DCs, and neu-
trophils (Robertson et al. 1992, 1996a).
Interestingly, it has been shown that intradermal
injection of recombinant GM-CSF in patients with
leprosy (Kaplan et al. 1992) or in mice (O’Sullivan
et al. 1996) results in recruitment of langerhans cells in
the skin. In mice, GM-CSF mRNA expression and protein
secretion are upregulated 20-fold after insemination
(Robertson et al. 1992). It is notable that GM-CSF mRNA
expression remains elevated for 48 h and then declines
as progesterone levels increase on day 3 and day 4 of
pregnancy (Robertson et al. 1996a).
There is no direct evidence to show that progesterone
may play a role in DC recruitment to the female
reproductive tract, but it seems that this hormone may
inhibit DC recruitment through downregulation of
GM-CSF production. Pretreatment of ovariectomized
mice with estradiol, but not progesterone, resulted in the
induction of GM-CSF production and estradiol-induced
increase was inhibited by the co-administration of
progesterone (Robertson et al. 1996b). As pregnancy
proceeds, the progesterone level increases and thus it is
conceivable that the frequency of decidual DCs declines
with the progression of pregnancy. This hypothesis is in
line with our findings. Indeed, in rats, progesterone
levels peak at mid-gestation (Varga et al. 1981) when,
according to our results, the frequency of splenic or
decidual DCs declines to its lowest level.
Comparing the relative frequency of decidual lym-
phoid and myeloid DCs, we found that except for the
mid-gestation, MDCs predominate. In mice, MDCs shift
T cell responses toward Th2 immunity and considering
that the Th2 response is necessary for a successful
pregnancy, our findings can be explained. Predomi-
nancy of the LDC subset (which promotes Th1 immunity)
at mid-gestation, however, seems to be contrary to the
established Th2 paradigm of pregnancy.
In general, LDCs induce a limited CD4CT cell
response that is associated with marked T cell apoptosis
and induction of tolerance (Inaba et al. 1997, Vandena-
beele & Wu 1999, Banchereau et al. 2000). Therefore, it
may be suggested that the predominancy of decidual
LDCs at mid-gestation may serve as an important role in
controlling destructive responses of maternal immune
system against paternal antigens through induction of
immunological tolerance. Our findings also propounded
another explication for this phenomenon. We found that
treatment of DCs with decidual supernatant obtainedwww.reproduction-online.org
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Kinetics of murine decidual dendritic cells 281from allogenic pregnant mice at mid-gestation markedly
blocked their ability to induce antigen-specific IFNg
production by cultured lymph node cells (A H Zarnani,
unpublished observations). Thus, this Th2 promoting
effect of uterine microenvironment could compensate
for inherent Th1-skewing capacity of LDCs. There are
plenty of reports indicating that the main functional
properties of DCs, i.e., antigen presentation and Th1/Th2
induction capacity, are controlled by environmental
instructions (Stumbles et al. 1998, Kapsenberg et al.
1999, Liu et al. 2002, Vlad et al. 2003) and that the same
subset of DCs in different tissues is capable of inducing
distinct immune responses (Iwasaki & Kelsall 1999).
These explanations might be true for predominancy of
LDCs in the spleens of pregnant mice.
In a recent study, Blois et al. (2004a) found lower
frequency of splenic and uterine CD11cC DCs at early
pregnancy and that frequency of such cells reached its
highest level at mid-gestation. In addition, in blood, the
percentage of LDCs was significantly highest at mid-
gestation, while uterine LDCs predominated at early
pregnancy. What we found in the present study is in
contrast to the above-mentioned findings. Although both
studies have monitored phenotype and lineage of DCs in
different periods of murine pregnancy, however, there
are some fundamental differences. First, in their study,
Blois et al. used CBA/J!DBA/2 model, which is known
to be abortion prone and according to the several reports
may suffer from many immunological defects leading to
abortion, including imbalance of DC population, as the
same group (Blois et al. 2004b) reported in their next
study that therapy with DCs normalize abortion rate in
this model. Indeed, in the CBA/J!DBA/2 model, fetal
resorption occurs at mid-gestation, a critical period that
according to Blois et al. and also our findings during
which major changes are happening, and it is interesting
to note that the major differences between findings of
Blois et al. and the present study are in this period.
Moreover, Rmochwal-Kolarz (2003a) also reported
lower frequency of peripheral blood DCs in the second
trimester of normal human pregnancy supporting the
data presented here. On the other hand, according to
Blois et al., the percentage of the uterine CD11cC cells
at mid-gestation is about 15%, which is unexpectedly
high, as the frequency of these cells in such lymphoid
organs as spleen, which is heavily populated by DCs is
around 1.5% (Steinman & Cohn 1973, Zarnani et al.
2006). Second, we analyzed decidual and splenic DCs
instead of looking at uterine and peripheral blood DCs,
which might be different in terms of DC frequency or
phenotype. Third, completely different methods (immu-
nohistochemistry versus flow cytometry) have been used
for immunophenotyping of DCs in these studies.
Differential recruitment of MDCs and LDCs to the feto-
maternal interface at different stages of pregnancy is
probably influenced by different arrays of chemokines
produced in situ (Kayisli et al. 2002, Penna et al. 2002).www.reproduction-online.orgConversely, different subsets of DCs could modulate the
outgoing immune response through production of
different chemokines, which are able to recruit Th1/
Th2/Treg cells (Bonecchi et al. 1998, Loetscher et al.
1998, Iellem et al. 2001, Sebastiani et al. 2001).
In conclusion, we characterized distribution and
immunophenotype, with emphasis on myeloid and
lymphoid markers, of CD11cC DCs in the decidua and
spleen of pregnant mice during different stages of
gestation. Data presented here, reveal that frequency
and subset of splenic and decidual DCs are finely tuned
in a timely manner throughout pregnancy. Therefore,
such balance may be relevant to the immunology of
successful pregnancy and shed light on the complex
networks of immunoregulation at the feto-maternal
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